These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 1524068)

  • 1. Preventability and severity assessment in reporting adverse drug reactions.
    Hartwig SC; Siegel J; Schneider PJ
    Am J Hosp Pharm; 1992 Sep; 49(9):2229-32. PubMed ID: 1524068
    [No Abstract]   [Full Text] [Related]  

  • 2. Development, implementation, and results of a successful multidisciplinary adverse drug reaction reporting program in a university teaching hospital.
    Murphy BM; Frigo LC
    Hosp Pharm; 1993 Dec; 28(12):1199-204, 1240. PubMed ID: 10130617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Control charts to monitor rates of adverse drug reactions.
    Schumock GT; Seeger JD; Kong SX
    Hosp Pharm; 1995 Dec; 30(12):1088, 1091-2, 1095-6. PubMed ID: 10153656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of pharmacists to the reporting of adverse drug reactions.
    van Grootheest AC; van Puijenbroek EP; de Jong-van den Berg LT
    Pharmacoepidemiol Drug Saf; 2002; 11(3):205-10. PubMed ID: 12051119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased adverse drug reaction reporting through wall-mounted ADR reporting cards.
    Szymusiak-Mutnick BA; Ross MB
    Formulary; 1995 Aug; 30(8):471-3. PubMed ID: 10151735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, comparative methods of detection, and preventability of adverse drug events.
    Al-Tajir GK; Kelly WN
    Ann Pharmacother; 2005; 39(7-8):1169-74. PubMed ID: 15928265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reaction program using pharmacist and nurse monitors.
    Miwa LJ; Randall RJ
    Hosp Formul; 1986 Nov; 21(11):1140-3, 1146. PubMed ID: 10279322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse drug reactions among children over a 10-year period.
    Le J; Nguyen T; Law AV; Hodding J
    Pediatrics; 2006 Aug; 118(2):555-62. PubMed ID: 16882807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions: the San Juan Department of Veterans Affairs Medical Center experience.
    Nazario M; Feliú JF; Rivera GC
    Hosp Pharm; 1994 Mar; 29(3):244-6, 249-50. PubMed ID: 10171808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidisciplinary adverse drug reaction surveillance program.
    Prosser TR; Kamysz PL
    Am J Hosp Pharm; 1990 Jun; 47(6):1334-9. PubMed ID: 2368727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Re-evaluating reporting rates for adverse drug reactions.
    Sweet BV; Ryan ML
    Am J Hosp Pharm; 1994 Jan; 51(1):122. PubMed ID: 8135251
    [No Abstract]   [Full Text] [Related]  

  • 12. Formulary management at a tertiary care teaching hospital.
    Mutnick AH; Ross MB
    Pharm Pract Manag Q; 1997 Apr; 17(1):63-87. PubMed ID: 10166245
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of the development of a multidisciplinary adverse drug reaction committee.
    Etzel JV; Brocavich JM; Rousseau M
    Hosp Pharm; 1995 Dec; 30(12):1083-7. PubMed ID: 10153655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adverse effects of drugs--25 years later].
    Poulsen HE
    Ugeskr Laeger; 1997 Aug; 159(33):4964. PubMed ID: 9281208
    [No Abstract]   [Full Text] [Related]  

  • 15. A medication use evaluation of alendronate: compliance with administration guidelines.
    Mersfelder T; Armitstead JA; Ivey MF; Cedars M
    Pharm Pract Manag Q; 1999 Jan; 18(4):50-8. PubMed ID: 10339068
    [No Abstract]   [Full Text] [Related]  

  • 16. Adverse drug reactions and avalanches: life at the edge of chaos.
    Frattarelli DA
    J Clin Pharmacol; 2005 Aug; 45(8):866-71. PubMed ID: 16027396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achieving an effective committee through reorganization: the Ohio State University Hospital's experience.
    Lewis RP; Moore TD
    Hosp Formul; 1991 Feb; 26(2):120-30. PubMed ID: 10109143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved reporting of adverse drug reactions.
    Kimelblatt BJ; Young SH; Heywood PM; Mandala AR; Gendelman S; Mehl B
    Am J Hosp Pharm; 1988 May; 45(5):1086-9. PubMed ID: 3400650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unusual and severe forms of adverse drug reactions.
    Gogtay N; Mangalvedhekar S; Kshirsagar NA
    J Assoc Physicians India; 1999 Aug; 47(8):847. PubMed ID: 10778648
    [No Abstract]   [Full Text] [Related]  

  • 20. Adverse drug reaction surveillance in an emergency room.
    Stoukides CA; D'Agostino PR; Kaufman MB
    Am J Hosp Pharm; 1993 Apr; 50(4):712-4. PubMed ID: 8470691
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.